Xiangya Hospital of Central South University
Changsha, Hunan, 410000, China
Location status: Recruiting
Location contact
Jifeng Guo, Ph.D.
CONTACT
Qiying Sun, Ph.D.
CONTACT
NCT Number: NCT03508960
The purpose of the Chinese Early-onst Parkinson's disease Registry (CEOPDR) is to develop a database of persons with early-onset Parkinson's disease (EOPD) in China.
Interested in participating?
Request InfoUp to 50 year
All sexes
Observational
Changsha, Hunan, 410000, China
Location status: Recruiting
Jifeng Guo, Ph.D.
CONTACT
Qiying Sun, Ph.D.
CONTACT
Parkinson's disease (PD) is the second most common disorder among degenerative neurological disease. Early-onset PD (EOPD) has its unique clinical feature and genetic basis.Investigators aim to establish a database of EOPD,and characterize the clinical feature, genetic basis, environmental factors and their interactions EOPD in China.
Method:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 years
To collect 3000 patients with early-onset parkinson's disease and establish the database of early-onset Parkinson's disease in mainland China.
Time frame: 10 years
To characterize clinical feature and environmental factors among Chinese early-onset parkinson's disease
Time frame: 10 years
To characterize the genetic basis of Chinese EOPD and detect clinically relevant genetic variants in these cases.
Contact information is provided by the study sponsor or research team.
Beisha Tang, Ph.D.
CONTACT
J Guo, Ph.D.
CONTACT
Xiangya Hospital of Central South University
Other
The Chinese Early-onset Parkinson's Disease Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06680830
Basal Ganglia Diseases, Brain Diseases
Sun City, Arizona, United States
View Trial DetailsNCT07323121
Basal Ganglia Diseases, Brain Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT04477785
Anosmia, Basal Ganglia Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07710625
Basal Ganglia Diseases, Brain Diseases
Istanbul, Turkey, Turkey (Türkiye)
View Trial Details